Combined-modality therapy for primary central nervous system lymphoma: Long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group)
- 1 February 2006
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 64 (2) , 408-413
- https://doi.org/10.1016/j.ijrobp.2005.07.958
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Is Withdrawal of Consolidation Radiotherapy an Evidence-Based Strategy in Primary Central Nervous System Lymphomas?Journal of Clinical Oncology, 2004
- High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962Journal of Clinical Oncology, 2003
- Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy.Journal of Neuro-Oncology, 2003
- Primary Central Nervous System Lymphoma: Time to Ask the QuestionJournal of Clinical Oncology, 2002
- A multicenter study of treatment of primary CNS lymphomaNeurology, 2002
- A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphomaCancer, 2000
- Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS LymphomaJournal of Clinical Oncology, 2000
- Long-term survival in primary CNS lymphoma.Journal of Clinical Oncology, 1998
- Primary central nervous system non-hodgkin's lymphoma: Survival advantages with combined initial therapy?International Journal of Radiation Oncology*Biology*Physics, 1995
- Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcomeJournal of Neurosurgery, 1994